Opportunity ID: 358801
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | HT942525DMDRPIDA |
| Funding Opportunity Title: | DOD Duchenne Muscular Dystrophy, Idea Development Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | May 01, 2025 |
| Last Updated Date: | May 23, 2025 |
| Original Closing Date for Applications: | Aug 08, 2025 |
| Current Closing Date for Applications: | Aug 08, 2025 |
| Archive Date: | Sep 07, 2025 |
| Estimated Total Program Funding: | $2,500,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: |
Summary: The fiscal year 2025 (FY25) Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with Duchenne muscular dystrophy (DMD). Applications should include a well-formulated, testable hypothesis based on strong scientific rationale. Distinctive Features: The FY25 DMDRP IDA mechanism has a New Investigator category for applicants early in their careers (i.e., within 10 years of their first faculty appointment or equivalent) or for established investigators new to DMD research. • The New Investigator – Early Stage category is designed to allow applicants early in their faculty appointments to compete for funding separately from established investigators. • The New Investigator – Transitioning category is designed for investigators in an area other than muscular dystrophy, at or above the level of Assistant Professor, seeking to transition to a career in DMD, thereby bringing their expertise to the field. Preliminary data relevant to DMD that supports the feasibility of the research hypotheses and research approaches are required. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Pages 4 and 10 of the Program Announcement (PA) have been updated to reflect a change in the funding details from a total direct cost cap to a total cost cap. Additionally, the Estimated Total Program Funding amount has been updated in the PA and synopsis. | May 23, 2025 | |
| May 01, 2025 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | HT942525DMDRPIDA |
| Funding Opportunity Title: | DOD Duchenne Muscular Dystrophy, Idea Development Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | May 01, 2025 |
| Last Updated Date: | May 23, 2025 |
| Original Closing Date for Applications: | Aug 08, 2025 |
| Current Closing Date for Applications: | Aug 08, 2025 |
| Archive Date: | Sep 07, 2025 |
| Estimated Total Program Funding: | $2,500,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: |
Summary: The fiscal year 2025 (FY25) Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with Duchenne muscular dystrophy (DMD). Applications should include a well-formulated, testable hypothesis based on strong scientific rationale. Distinctive Features: The FY25 DMDRP IDA mechanism has a New Investigator category for applicants early in their careers (i.e., within 10 years of their first faculty appointment or equivalent) or for established investigators new to DMD research. • The New Investigator – Early Stage category is designed to allow applicants early in their faculty appointments to compete for funding separately from established investigators. • The New Investigator – Transitioning category is designed for investigators in an area other than muscular dystrophy, at or above the level of Assistant Professor, seeking to transition to a career in DMD, thereby bringing their expertise to the field. Preliminary data relevant to DMD that supports the feasibility of the research hypotheses and research approaches are required. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | HT942525DMDRPIDA |
| Funding Opportunity Title: | DOD Duchenne Muscular Dystrophy, Idea Development Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 3 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 01, 2025 |
| Last Updated Date: | May 01, 2025 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Aug 08, 2025 |
| Archive Date: | Sep 07, 2025 |
| Estimated Total Program Funding: | $1,680,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: |
Summary: The fiscal year 2025 (FY25) Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with Duchenne muscular dystrophy (DMD). Applications should include a well-formulated, testable hypothesis based on strong scientific rationale. Distinctive Features: The FY25 DMDRP IDA mechanism has a New Investigator category for applicants early in their careers (i.e., within 10 years of their first faculty appointment or equivalent) or for established investigators new to DMD research. • The New Investigator – Early Stage category is designed to allow applicants early in their faculty appointments to compete for funding separately from established investigators. • The New Investigator – Transitioning category is designed for investigators in an area other than muscular dystrophy, at or above the level of Assistant Professor, seeking to transition to a career in DMD, thereby bringing their expertise to the field. Preliminary data relevant to DMD that supports the feasibility of the research hypotheses and research approaches are required. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
Related Documents
Packages
| Agency Contact Information: | CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org Email: help@eBRAP.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00290678 | May 01, 2025 | Aug 08, 2025 | View |
Package 1
Mandatory forms
Optional forms
Share This Post, Choose Your Platform!
About the Author: osnqt
